ROBERT CAREY

Corporate Board Profile

Tech Score: 0/100

TAYLOR DEVICES, INC.

Filing Date	Source Excerpt
2020-09-11	Class 3 Director Whose Term Will Expire in 2022 Robert Carey, 75, brings over 45 years of experience ranging from General Management to consultative. He was the General Manager of the Reichert Analytical Instruments group from 2001 to 2009. The company manufactures and sells internationally a variety of analytical measurement instruments for use in medicine, food processing, and biotechnology research. Mr. Carey was the Principal at CMA, Ltd from 1990 to 2001. CMA, Ltd provides consulting services to the manufacturing sector in the area of organization, operational change and strategic planning. Mr. Carey was also a Partner in Decision Processes International (DPI) from 1999 to 2001. DPI is an international strategic planning consultancy working with companies of all sizes. In 1979 Mr. Carey joined Wilson Greatbatch Ltd. (now Integer Holdings) as North American Sales Manager. Mr. Greatbatch held the patents for the implantable pacemaker. The eponymously named company is the world’s leader in implantable power sources. In 1981 Mr. Carey was named Vice President of Wilson Greatbatch and General Manager of the Electrochem Div. Electrochem manufactures, and sells internationally, high energy batteries used in rugged or remote environments such as space, oil and gas drilling, the military and the ocean. He earned a Bachelor of Science in Microbiology from the State University of California, Long Beach and a Master of Business Administration from the State University of New York at Buffalo. Mr. Carey served in the U.S. Army achieving the rank of Captain. The Company believes that Mr. Carey’s experience in strategic planning for technical manufacturing companies and his knowledge of lean manufacturing, related statistical techniques, and team based organization structures qualify him to serve as a member of the Board of Directors. If elected by the shareholders, Mr. Carey will be an independent director within the meaning of Rule 5605, and the Company anticipates that the Board will appoint Mr. Carey to the Audit, Compensation, and Nominating Committees.

Filing Date

Source Excerpt

2020-09-11

Class 3 Director Whose Term Will Expire in 2022 Robert Carey, 75, brings over 45 years of experience ranging from General Management to consultative. He was the General Manager of the Reichert Analytical Instruments group from 2001 to 2009. The company manufactures and sells internationally a variety of analytical measurement instruments for use in medicine, food processing, and biotechnology research. Mr. Carey was the Principal at CMA, Ltd from 1990 to 2001. CMA, Ltd provides consulting services to the manufacturing sector in the area of organization, operational change and strategic planning. Mr. Carey was also a Partner in Decision Processes International (DPI) from 1999 to 2001. DPI is an international strategic planning consultancy working with companies of all sizes. In 1979 Mr. Carey joined Wilson Greatbatch Ltd. (now Integer Holdings) as North American Sales Manager. Mr. Greatbatch held the patents for the implantable pacemaker. The eponymously named company is the world’s leader in implantable power sources. In 1981 Mr. Carey was named Vice President of Wilson Greatbatch and General Manager of the Electrochem Div. Electrochem manufactures, and sells internationally, high energy batteries used in rugged or remote environments such as space, oil and gas drilling, the military and the ocean. He earned a Bachelor of Science in Microbiology from the State University of California, Long Beach and a Master of Business Administration from the State University of New York at Buffalo. Mr. Carey served in the U.S. Army achieving the rank of Captain. The Company believes that Mr. Carey’s experience in strategic planning for technical manufacturing companies and his knowledge of lean manufacturing, related statistical techniques, and team based organization structures qualify him to serve as a member of the Board of Directors. If elected by the shareholders, Mr. Carey will be an independent director within the meaning of Rule 5605, and the Company anticipates that the Board will appoint Mr. Carey to the Audit, Compensation, and Nominating Committees.

Data sourced from SEC filings. Last updated: 2025-07-16